Article

Miltefosine enhances infectivity of miltefosine-resistant Leishmania infantum by…

medRxiv · 2021 · Bulte, D.; Van Bockstal, L.; Dirkx, L. W.; Van den Kerkhof, M.; De Trez, C.; Timmermans, J.-P.; Hendrickx, S.; Maes, L.; Caljon, G.

Key facts

Title Miltefosine enhances infectivity of miltefosine-resistant Leishmania infantum by attenuating innate immune recognition
First author Bulte, D.; Van Bockstal, L.; Dirkx, L. W.; Van den Kerkhof, M.; De Trez, C.; Timmermans, J.-P.; Hendrickx, S.; Maes, L.; Caljon, G.
Journal medRxiv
Published Feb 25, 2021
DOI 10.1101/2021.02.22.432409
Devices mentioned K810863
Product codes mentioned DBM, JJH, MVU, MVW, MZF

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature